The pharmaceutical sector has issued a strident, urgent plea to the Health Department. They are imploring officials to immediately reconsider the newly gazetted 1.4% SEP increase in the maximum Single Exit Price (SEP) for medicines in 2026. The adjustment, set at a...
For millions of South Africans grappling with the rising cost of living, the announcement that medical scheme contribution increases for 2026 will largely remain within single digits offers a welcome reprieve. However, industry experts warn that these restrained...
Novo Nordisk has unveiled promising new findings from its OASIS 4 phase 3 trial. The findings suggest that a daily Wegovy weight-loss pill could serve as a highly effective alternative to the widely used injectable formulation. The pharmaceutical giant’s latest data...
The Council for Medical Schemes (CMS) has officially released its CMS Industry Report 2024. This document offers the first fully integrated review of the sector since 2022. It merges critical data on healthcare utilisation with a comprehensive financial assessment....
As climate change accelerates the spread of pathogens worldwide, South Africa is positioning itself as a frontline defender of global health security. The nation is significantly enhancing its world-class bio-surveillance capabilities. Central to this strategy is the...
